Lantheus Holdings (LNTH) Treasury Shares (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Treasury Shares came in at $477.4 million in Q1 2026, up 172.82% year-on-year from $175.0 million in Q1 2025, and little changed on a QoQ basis from $477.4 million in Q4 2025.
Lantheus Holdings (LNTH) Treasury Shares (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 6 years of Treasury Shares data on file, last reported at $477.4 million in Q1 2026.
- On a quarterly basis, Treasury Shares rose 172.82% year-over-year to $477.4 million in Q1 2026; TTM through Mar 2026 was $477.4 million, a 172.82% increase from a year earlier, with the FY2025 full-year figure at $477.4 million, up 172.82% from the prior year.
- Treasury Shares for Q1 2026 stood at $477.4 million, roughly flat from $477.4 million in the prior quarter.
- Over the last five years, Treasury Shares for LNTH reached as high as $7.2 million in Q4 2025 and fell as low as $1339.0 in Q4 2022.
- Historically, Treasury Shares has averaged $2.3 million across 5 years, with a median of $1.3 million in 2023.
- Across the five-year window, Treasury Shares changed 0.0% in 2023 and soared 401.94% in 2025, its largest moves.
- Year by year, Treasury Shares stood at $75.0 million in 2022, then changed by 0.0% to $75.0 million in 2023, then surged by 133.33% to $175.0 million in 2024, then jumped by 172.82% to $477.4 million in 2025, then changed by 0.0% to $477.4 million in 2026.
- Per Business Quant data, the three most recent Treasury Shares figures were $477.4 million in Q1 2026, $477.4 million in Q4 2025, and $376.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 7.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.24 Mn |
| Mar 31, 2026 | 7.24 Mn |
| Mar 31, 2026 | 477.44 Mn |
| Mar 31, 2026 | 477.44 Mn |
| Dec 31, 2025 | 7.24 Mn |
| Dec 31, 2025 | 7.24 Mn |
| Dec 31, 2025 | 477.44 Mn |
| Dec 31, 2025 | 477.44 Mn |
| Sep 30, 2025 | 5.47 Mn |
| Sep 30, 2025 | 376.46 Mn |
| Sep 30, 2025 | 5.47 Mn |
| Sep 30, 2025 | 376.46 Mn |
| Jun 30, 2025 | 3.72 Mn |
| Jun 30, 2025 | 275.00 Mn |
| Jun 30, 2025 | 275.00 Mn |
| Jun 30, 2025 | 3.72 Mn |
| Mar 31, 2025 | 175.00 Mn |
| Mar 31, 2025 | 2,455.00 |
| Mar 31, 2025 | 2,455.00 |
| Mar 31, 2025 | 175.00 Mn |